Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinical Cancer Research

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14506160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours

  2003cited by this paper
• Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.

  2002cited by this paper
• Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.

  2002cited by this paper
• p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3

  2002cited by this paper
• Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

  2002influential reference
• Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.

  2002cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

  2002cited by this paper
• Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells

  2002cited by this paper
• Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma1

  2002cited by this paper
• Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.

  2002cited by this paper
• Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

  2001cited by this paper
• Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells

  2001cited by this paper
• Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.

  2001cited by this paper
• Anaplastic large cell lymphoma: pathological, molecular and clinical features.

  2001cited by this paper
• Translocations involving anaplastic lymphoma kinase (ALK)

  2001cited by this paper
• Activation of STAT proteins and growth control

  2001cited by this paper
• Molecular Characterization of a New ALK Translocation Involving Moesin (MSN-ALK) in Anaplastic Large Cell Lymphoma

  2001cited by this paper
• STAT3 is constitutively activated in Hodgkin cell lines.

  2001cited by this paper
• Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.

  2001cited by this paper
• Anaplastic large cell lymphoma: pathological, molecular and clinical features

  2001cited by this paper
• Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway.

  2000cited by this paper
• CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

  2000cited by this paper
• Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology.

  2000cited by this paper
• STAT proteins: novel molecular targets for cancer drug discovery

  2000cited by this paper
• ALK+ lymphoma: clinico-pathological findings and outcome.

  1999cited by this paper
• Stat3 as an oncogene.

  1999cited by this paper
• TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations.

  1999cited by this paper
• A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation.

  1999influential reference
• Distinct Mechanisms of Activation of Stat1 and Stat3 by Platelet-Derived Growth Factor Receptor in a Cell-Free System

  1999cited by this paper
• Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

  1999cited by this paper
• Nucleophosmin-Anaplastic Lymphoma Kinase of Large-Cell Anaplastic Lymphoma Is a Constitutively Active Tyrosine Kinase That Utilizes Phospholipase C-γ To Mediate Its Mitogenicity

  1998cited by this paper
• Activation and association of Stat3 with Src in v-Src-transformed cell lines

  1996cited by this paper
• Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.

  1995cited by this paper
• Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.

  1995cited by this paper
• Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

  1994cited by this paper
• Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

  1994influential reference
• Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

  1994cited by this paper
• Effect of alcohol on hepatic secretion of methylfolate (CH3H4PteGlu1) into bile.

  1981cited by this paper

• Anaplastic large cell lymphoma: unusual clinical and pathologic findings: A report of the 2023 SH-EA4HP Lymphoma Workshop.

  2025cites this paper
• Expression of JAK/STAT Signaling Proteins at Diagnosis and Remission in Patients with Acute Myeloid Leukemia.

  2024cites this paper
• Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art

  2024cites this paper
• Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

  2024cites this paper
• Systemic ALK-Negative Anaplastic Large Cell Lymphoma: Insights into Morphologic, Immunophenotypic, Genetic and Molecular Characteristics.

  2024cites this paper
• Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK- ALCL vs. CD30high PTCL, NOS

  2023cites this paper
• JAK/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK− Anaplastic Large Cell Lymphomas

  2022cites this paper
• Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma

  2022cites this paper
• 1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42) inhibits cell proliferation and induces apoptosis via inhibiting ALK and its downstream pathways in Karpas299 cells.

  2022cites this paper
• PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas

  2022cites this paper
• AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL

  2021cites this paper
• ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway

  2021influential citation
• Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma

  2021cites this paper
• Cellular and Molecular Mechanisms of Breast Implant–Associated Anaplastic Large Cell Lymphoma

  2020cites this paper
• Advances in targeted therapy for malignant lymphoma

  2020cites this paper
• SLAM family member 8 is expressed in and enhances the growth of anaplastic large cell lymphoma

  2020cites this paper
• ALK+ Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment

  2020cites this paper
• PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas

  2020cites this paper
• Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

  2019cites this paper
• Genomics of LGL leukemia and select other rare leukemia/lymphomas.

  2019cites this paper
• Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large-cell lymphomas.

  2019cites this paper
• PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma

  2019cites this paper
• Proteomic Phosphosite Analysis Identified Crucial NPM-ALK-Mediated NIPA Serine and Threonine Residues

  2019cites this paper
• Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma

  2019cites this paper
• Identification of the JAK-STAT pathway in canine splenic hemangiosarcoma, thyroid carcinoma, mast cell tumor, and anal sac adenocarcinoma.

  2019cites this paper
• Genetic subtyping of breast implant-associated anaplastic large cell lymphoma.

  2018cites this paper
• Mutations in the signal transducer and activator of transcription family of genes in cancer

  2018cites this paper
• The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)

  2018cites this paper
• Novel insights into the pathogenesis of T-cell lymphomas.

  2018cites this paper
• IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas

  2018cites this paper
• P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse‐free survival

  2018cites this paper
• Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.

  2018cites this paper
• Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model

  2018cites this paper
• Contrôle de l'expression de Bcl-2 dans les lymphomes anaplasiques à grandes cellules par la protéine HuR en réponse au crizotinib : impact sur l'apoptose et l'autophagie

  2017cites this paper
• JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomics.

  2017cites this paper
• PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma

  2017cites this paper
• Identification of the Presence and Activity of the JAK-STAT Pathway in Canine Tumors

  2017cites this paper
• Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.

  2017cites this paper
• Cytokine receptor signaling is required for the survival of ALK− anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations

  2017cites this paper
• Prioritization schema for immunotherapy clinical trials in glioblastoma

  2016cites this paper
• Cyclin D1 expression in peripheral T-cell lymphomas

  2016cites this paper
• Sensitivity Analysis of the NPM-ALK Signalling Network Reveals Important Pathways for Anaplastic Large Cell Lymphoma Combination Therapy

  2016cites this paper
• STAT3 Inhibitors in Cancer: A Comprehensive Update

  2016cites this paper
• Pathobiology ofALK anaplastic large-cell lymphoma

  2016cites this paper
• Rôle et régulation de l'autophagie dans les lymphomes anaplasiques à grandes cellules ALK positifs

  2016cites this paper
• The ALK Receptor Family

  2015cites this paper
• Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases

  2015cites this paper
• Crizotinib (PF-2341066) induces apoptosis due to downregulation of pSTAT3 and BCL-2 family proteins in NPM-ALK(+) anaplastic large cell lymphoma.

  2014cites this paper
• STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett’s adenocarcinomas

  2014cites this paper
• The role of STAT3 signaling in mediating tumor resistance to cancer therapy.

  2014cites this paper
• Molecular underpinning of extranodal NK/T-cell lymphoma.

  2013cites this paper
• The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update

  2013cites this paper
• Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1.

  2013cites this paper
• STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia

  2013cites this paper
• Pathology of Non-Hodgkin’s and Hodgkin’s Lymphomas

  2013cites this paper
• Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis

  2013cites this paper
• Molecular imaging for characterization of lymphoma biology and monitoring response to cancer drug therapy

  2013cites this paper
• ALK-immunoreactive neoplasms.

  2012cites this paper
• NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases

  2012cites this paper
• Survival Signals and Targets for Therapy in Breast Implant–Associated ALK− Anaplastic Large Cell Lymphoma

  2012cites this paper
• Constitutive STAT5 activation correlates with better survival in cervical cancer patients treated with radiation therapy.

  2012cites this paper
• β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

  2011cites this paper
• The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies

  2011cites this paper
• A multi-faceted approach to the diagnosis and treatment of pancreatic cancer

  2010cites this paper
• Tumorigenesis and Neoplastic Progression IL-21 Contributes to JAK 3 / STAT 3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma

  2010influential citation
• Prognostic significance of p‐STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy

  2010cites this paper
• Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated‐Stat3 correlates with poor prognosis

  2010cites this paper
• Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway

  2010cites this paper
• New Therapeutic Frontiers for Childhood Non-Hodgkin Lymphoma

  2010cites this paper
• Anaplastic large cell lymphoma in adults

  2010cites this paper
• Frequent STAT3 activation is associated with Mcl‐1 expression in nasal NK‐cell lymphoma

  2009influential citation
• Transforming growth factor beta-induced tyrosine phosphorylation of signal transducer and activator of transcription 3 and cellular invasion is mediated by interleukin-6 secretion in breast cancer cell lines

  2009cites this paper
• Anaplastic lymphoma kinase: signalling in development and disease

  2009cites this paper
• pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation

  2009cites this paper
• Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators

  2008cites this paper
• Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers.

  2008cites this paper
• Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.

  2008cites this paper
• Characterization of Some Molecular Mechanisms Governing Autoactivation of the Catalytic Domain of the Anaplastic Lymphoma Kinase*

  2008cites this paper
• The Incidence, Correlation with Tumor Infiltrating Inflammation, and Prognosis of p-STAT3 Expression in Human Gliomas

  2008cites this paper
• Investigating the function of Anaplastic Lymphoma Kinase

  2008cites this paper
• Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma.

  2008cites this paper
• The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas

  2008cites this paper
• Rôle des GTPases de la famille Rho et de leurs régulateurs dans les propriétés transformantes des lymphomes anaplasiques NPM-ALK positifs

  2007cites this paper
• Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma: A report from the children's oncology group.

  2007cites this paper
• Pathobiology of ALK+ anaplastic large-cell lymphoma.

  2007cites this paper
• Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.

  2007cites this paper
• The STAT3 oncogene as a predictive marker of drug resistance.

  2007cites this paper
• Rôle des facteurs de transcription stat3 dans la réponse aux inhibiteurs de topoisomerase : Implication dans la résistance aux traitements de chimiothérapie

  2006cites this paper
• Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma.

  2006cites this paper
• STAT3 is activated in a subset of the Ewing sarcoma family of tumours

  2006cites this paper
• JSI‐124 (cucurbitacin I) inhibits Janus kinase‐3/signal transducer and activator of transcription‐3 signalling, downregulates nucleophosmin‐anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK‐positive anaplastic large cell lymphoma cells

  2006cites this paper
• Three childhood malignancies with striking morphologic and phenotypic similarities

  2006cites this paper
• Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs.

  2006cites this paper
• Restoration of shp1 expression by 5-AZA-2′-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma

  2006cites this paper
• Activation of STAT3, MAPK, and AKT in Malignant Astrocytic Gliomas: Correlation With EGFR Status, Tumor Grade, and Survival

  2006cites this paper
• Loss of SHP 1 enhances JAK 3 / STAT 3 signaling and decreases proteosome degradation of JAK 3 and NPM-ALK in ALK anaplastic large-cell lymphoma

  2006cites this paper
• Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour

  2006cites this paper
• Loss of SHP 1 Enhances JAK 3 / STAT 3 Signaling and Decreases Proteosome Degradation of JAK 3 and NPM-ALK in ALK-positive Anaplastic Large Cell Lymphoma

  2006cites this paper
• Childhood and adolescent non‐Hodgkin lymphoma: New insights in biology and critical challenges for the future

  2005cites this paper
• ANAPLASTIC LARGE CELL LYMPHOMA WITH ALK EXPRESSION AND PRESENCE OF THE t(2;5) TRANSLOCATION IN A 5-MONTH-OLD INFANT

  2005cites this paper